Study: Diabetes Drug May Cut Risk of Alzheimer’s and Parkinson’s …
WEB2 hours ago · SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, according to a large study. Results showed a 20% to 30% lower risk for these conditions, though further research is needed for long-term validation. According to a study …
Do people with Parkinson’s always develop dementia? - Medical News Today
WEBAug 14, 2024 · Dementia for people with Parkinson’s disease may occur less often, and when it does occur, it may develop later than thought, a new study suggests.
Parkinson’s Disease Dementia: What It Is, Symptoms & Stages
WEBJul 8, 2024 · Parkinson’s disease dementia is a decline in thinking and reasoning skills that can develop after a Parkinson’s disease diagnosis. Learn about the common symptoms, risk factors, diagnosis and treatment options for this condition that affects memory, attention, language and behavior.
Parkinson's Dementia: Stages, Symptoms, Causes, and Outlook
WEBNov 15, 2023 · Parkinson's dementia (PDD) is a feature of Parkinson's disease that causes cognitive and behavioral problems. Learn about the symptoms, diagnosis, risk factors, and treatment of PDD, and how it differs from dementia with Lewy bodies (DLB).
Novel drug molecule could help treat Parkinson's disease in …
WEB3 days ago · While Parkinson's symptoms—slowed movements, tremors, and balance problems—often appear in people in their 60s, onset at an earlier age is not uncommon and five to 10% of people diagnosed are ...
PET scans may predict Parkinson’s disease and Lewy body dementia …
WEBNov 7, 2023 · In a small study, researchers at the National Institutes of Health have found that positron emission tomography (PET) scans of the heart may identify people who will go on to develop Parkinson’s disease or Lewy body dementia among those at …
Parkinson disease-associated cognitive impairment - Nature
WEBJul 1, 2021 · Cognitive impairment is common in patients with Parkinson disease and ranges in severity. This Primer reviews the epidemiology, pathophysiology, diagnosis and treatment of cognitive impairment...
Parkinson’s Disease | New England Journal of Medicine
WEBJul 31, 2024 · Parkinson’s disease–related dementia may decrease modestly in response to treatment with acetylcholinesterase inhibitors or memantine, but only rivastigmine is classified as...
Parkinson's Dementia Patients on Anavex 2-73 Show Range of …
WEBMar 17, 2022 · Anavex 2-73 (blarcamesine), an investigational oral therapy for Parkinson’s disease dementia, led to clinically meaningful improvements within all four MDS-UPDRS assessments for patients treated daily at high dose, according to new data from a completed Phase 2 trial.
Parkinson’s disease, dementia linked to ... - Medical News Today
WEBNov 17, 2023 · Nanoplastics may affect a specific protein found in the brain, causing changes linked to Parkinson's disease and other types of dementia, a recent study suggests.